9,10-Dehydro Epirubicin - Request Quote
9,10-Dehydro Epirubicin
| SZ CAT No: | SZ-E045012 |
| CAS No | NA |
| Mol.F. | C27H27NO10 |
| Mol.Wt. | 525.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
9,10-Dehydro Epirubicin is chemically (S)-7-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,11-dihydroxy-9-(2-hydroxyacetyl)-4-methoxy-7,8-dihydrotetracene-5,12-dione. 9,10-Dehydro Epirubicin is supplied with detailed characterization data compliant with regulatory guideline. 9,10-Dehydro Epirubicin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Epirubicin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality 9,10-Dehydro Epirubicin
Purchase 9,10-Dehydro Epirubicin
9,10-Dehydro Epirubicin suppliers
9,10-Dehydro Epirubicin manufacturers
9,10-Dehydro Epirubicin price
Order 9,10-Dehydro Epirubicin
Enquire 9,10-Dehydro Epirubicin
9,10-Dehydro Epirubicin cost
9,10-Dehydro Epirubicin Supplier
9,10-Dehydro Epirubicin Distributor
9,10-Dehydro Epirubicin for Method Validation
Epirubicin Reference Standard
9,10-Dehydro Epirubicin for ANDA Filing
9,10-Dehydro Epirubicin for Forced Degradation Studies
9,10-Dehydro Epirubicin Identification Standards
9,10-Dehydro Epirubicin for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


